Cost/benefit analysis of cancer drugs].

Bertrand Jordan

Medecine sciences : M/S 2020 Nov

filter terms:

benefit costs (1)

cost benefit analysis (2)

drug costs (1)

drug industry (1)

ethics (1)

health care costs (1)

humans (1)

pharmacy (1)

prices (1)

treatment costs (1)

Sizes of these terms reflect their relevance to your search.

A detailed analysis of the clinical benefit for 47 approved cancer drugs, using two internationally recognized assessment systems, shows essentially no correlation between clinical benefit and weekly treatment costs. This is true both in the USA and in four European countries, although prices are dramatically lower in Europe. © 2020 médecine/sciences – Inserm.